Sanofi BTK inhibitor successful in mid-stage MS study [Seeking Alpha]
PRINCIPIA BIOPHARMA INC COMMON (PRNB)
Last principia biopharma inc common earnings: 11/5 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
HealthcareSanofi BTK inhibitor successful in mid-stage MS studyApr. 23, 2020 6:41 AM ET|Sanofi (SNY)Douglas W. HouseSanofi (NASDAQ:positive resultsPhase 2b clinical trialThe study met the primary endpoint demonstrating significantly reduced disease activity as measured by the number of new Gd-enhancing T1 hyperintense lesions detected by brain magnetic resonance imaging (MRI).Four doses were tested (5 mg-60 mg) for 12 weeks compared to placebo. Participants receiving 60 mg showed an 85% relative reduction in new Gd-enhancing T1 hyperintense lesions and an 89% relative reduction in T2 hyperintense lesions (secondary endpoint).No new safety signals were observed.The company plans to initiate four Phase 3 trials in relapsing and progressive forms of MS.Sanofi in-licensed global rights to the candidate from Principia Biopharma (NASDAQ:PRNBNovember 2017 agreementClick to subscribe to real-time analytics on SNYNow read:Abbott Labs' Diversification And Diagnostics Leverage Paying Off Now »
Show less
Read more
Impact Snapshot
Event Time:
PRNB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRNB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRNB alerts
High impacting PRINCIPIA BIOPHARMA INC COMMON news events
Weekly update
A roundup of the hottest topics